Cellulitis and Haematocrit decreased

Summary:

Haematocrit decreased is found among people with Cellulitis, especially for people who are female, 60+ old.

The study analyzes which people have Haematocrit decreased with Cellulitis. It is created by eHealthMe based on reports of 29 people who have Cellulitis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Cellulitis?

Cellulitis (infection under the skin) is found to be associated with 2,080 drugs and 2,338 conditions by eHealthMe. Check the latest studies of Cellulitis.

What is Haematocrit decreased?

Haematocrit decreased is found to be associated with 1,630 drugs and 2,399 conditions by eHealthMe. Check the latest studies of Haematocrit decreased.

On Jul, 27, 2026

29 people who have Cellulitis and Haematocrit Decreased are studied.

Would you have Haematocrit decreased when you have Cellulitis?

Gender of people who have Cellulitis and experienced Haematocrit Decreased *:

female: 73.08 %
male: 26.92 %

Age of people who have Cellulitis and experienced Haematocrit Decreased *:

Common co-existing conditions for these people *:

Vasculitis (inflammation of a blood vessel or blood vessels): 4 people, 13.79%
Microscopic Polyangiitis (inflammation involving multiple blood or lymph small-vessel): 4 people, 13.79%
High Blood Cholesterol: 3 people, 10.34%
Skin Ulcer: 2 people, 6.90%
Pain: 2 people, 6.90%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 2 people, 6.90%
Neoplasm Malignant (cancer tumour): 2 people, 6.90%
Gastrointestinal Neoplasm (cancer tumour of digestive tract): 2 people, 6.90%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 3.45%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 3.45%

Common drugs taken by these people *:

Common symptoms for these people *:

Haemoglobin Decreased: 20 people, 68.97%
White Blood Cell Count Decreased: 9 people, 31.03%
Lymphocyte Count Decreased: 8 people, 27.59%
Red Cell Distribution Width Increased: 7 people, 24.14%
Red Blood Cell Count Decreased: 7 people, 24.14%
Drug Hypersensitivity: 6 people, 20.69%
Fever: 6 people, 20.69%
Hyperkalemia (damage to or disease of the kidney): 6 people, 20.69%
Rashes (redness): 6 people, 20.69%
Blood Creatinine Increased: 5 people, 17.24%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Haematocrit decreased?

- Check whether Haematocrit decreased is associated with a drug or a condition

Related publications that referenced our studies

Yaylaci S, Yilmaz EU, Guclu E, Kumsar NA, Tamer A, Karabay O, "Clozapine-Induced Febrile Neutropenia and Cellulitis", Turkish journal of emergency medicine, 2014 Mar .
Yaylaci S, Yilmaz EU, Guclu E, Kumsar NA, Tamer A, Karabay O, "Clozapine-Induced Febrile Neutropenia and Cellulitis", Turkish journal of emergency medicine, 2014 Mar .

Related studies:

Treatments, associated drugs and conditions:

Cellulitis (75,290 reports)
Haematocrit decreased (34,100 reports)

All the drugs that are associated with Haematocrit decreased:

Haematocrit decreased (1,630 drugs)

All the conditions that are associated with Haematocrit decreased:

Haematocrit decreased (2,399 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Haematocrit decreased and Cellulitis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.